Goal Vest Advisory LLC Novartis Ag Transaction History

Goal Vest Advisory LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 02, 2024	SELL	$92.27 - $101.54 $17,992 - $19,800	-195 Reduced 71.69%	77 $7,000
Q3 2023 Oct 10, 2023	BUY	$94.73 - $105.13 $8,146 - $9,041	86 Added 46.24%	272 $27,000
Q2 2023 Jul 17, 2023	BUY	$92.52 - $104.91 $17,208 - $19,513	186 New	186 $18,000
Q2 2022 Jul 06, 2022	SELL	$80.52 - $93.75 $291,562 - $339,468	-3,621 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$80.11 - $90.62 $49,507 - $56,003	-618 Reduced 14.58%	3,621 $318,000
Q2 2021 Sep 01, 2021	BUY	$85.24 - $94.15 $361,332 - $399,101	4,239 New	4,239 $387,000
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $668 - $787	-8 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$78.07 - $94.43 $624 - $755	8 New	8 $1,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Goal Vest Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Goal Vest Advisory LLC with notifications on news.